Imipramine-mediated Suppression of EGFR Signaling Attenuates Invasive and Progressive Abilities of Hepatocellular Carcinoma Cells. Fu CY, Liao PA, Lin TH, Hsu FT, et al. Anticancer Res 2024;44:5323-5335.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fu CY, Liao PA, Lin TH, Hsu FT, et al. Imipramine-mediated Suppression of EGFR Signaling Attenuates Invasive and Progressive Abilities of Hepatocellular Carcinoma Cells. Anticancer Res 2024;44:5323-5335.
PMID: 39626916